Hai Zheng Pharmaceutical (600267.SH): Tigecycline raw material drug obtains CEP certificate.

Zhtng Cijng APP News, Haizheng Pharmaceutical (600267.SH) announced that the company recently received the Certificate of Suitability of the European Pharmacopoeia (CEP certificate) for its Tigecycline Active Pharmaceutical Ingredient issued by the European Directorate for the Quality of Medicines (EDQM).